Non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplant (HSCT) after admission to intensive care unit (ICU)

Ítems similars

• Mortality of oncohematologic patients admitted to the intensive care unit (icu) who required invasive mechanical ventilation (imv). do we have to delay intubation?
  per: Corcia Palomo, Y, et al.
  Publicat: (2015)
• How to treat VAP due to MDR pathogens in ICU patients
  per: Garnacho-Montero, José, et al.
  Publicat: (2014)
• Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
  per: Fisher, Sheila A, et al.
  Publicat: (2019)
• Late ICU admission in liver transplant recipients: ten years experience
  per: Atar, F, et al.
  Publicat: (2015)
• Outcome prediction in haematological patients requiring admission to the ICU
  per: Gopal, S, et al.
  Publicat: (2011)